• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020

Mary Wilson

Well-known member
Early Release / December 3, 2020 / 69

Kathleen Dooling, MD[SUP]1[/SUP]; Nancy McClung, PhD[SUP]1[/SUP]; Mary Chamberland, MD[SUP]1[/SUP][SUP],2[/SUP]; Mona Marin, MD[SUP]1[/SUP]; Megan Wallace, DrPH[SUP]1[/SUP][SUP],3[/SUP]; Beth P. Bell, MD[SUP]4[/SUP]; Grace M. Lee, MD[SUP]5[/SUP]; H. Keipp Talbot, MD[SUP]6[/SUP]; Jos? R. Romero, MD[SUP]7[/SUP]; Sara E. Oliver, MD[SUP]1[/SUP]

Summary


What is already known about this topic?

Demand is expected to exceed supply during the first months of the national COVID-19 vaccination program.

What is added by this report?

The Advisory Committee on Immunization Practices (ACIP) recommended, as interim guidance, that both 1) health care personnel and 2) residents of long-term care facilities be offered COVID-19 vaccine in the initial phase of the vaccination program.

What are the implications for public health practice?

Federal, state, and local jurisdictions should use this guidance for COVID-19 vaccination program planning and implementation. ACIP will consider vaccine-specific recommendations and additional populations when a Food and Drug Administration–authorized vaccine is available.

https://www.cdc.gov/mmwr/volumes/69/wr/mm6949e1.htm?s_cid=mm6949e1_e
 
Back
Top